GILEAD SCIENCES, INC. — Investor Relations & Filings
Filings indexed
1,975
across all filing types
Latest filing
2026-05-20
Regulatory Filings
Country
US
United States of America
Listing
US
GILD
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to address unmet medical needs. The company's primary focus is on virology, with a portfolio of transformative therapies for life-threatening diseases such as HIV/AIDS and viral hepatitis. Gilead is also expanding its impact in oncology and inflammation, maintaining a diverse pipeline of clinical programs across these key therapeutic areas. The company invests in scientific research to develop treatments for some of the world's most challenging diseases, aiming to improve the lives of patients globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-20 | English | |
| 424B5 | 2026-05-18 | English | |
| FWP | 2026-05-14 | English | |
| 424B5 | 2026-05-14 | English | |
| Regulatory Filings 2026 | 2026-05-08 | English | |
| S-8 - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46691604 | FORM 8-K | 2026-05-20 | English | ||
| 46459832 | 424B5 | 2026-05-18 | English | ||
| 46273906 | FWP | 2026-05-14 | English | ||
| 46012309 | 424B5 | 2026-05-14 | English | ||
| 46151278 | Regulatory Filings 2026 | 2026-05-08 | English | ||
| 43582483 | S-8 - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 43582866 | 10-Q - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 43481120 | 8-K - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 46151281 | FORM 8-K | 2026-05-04 | English | ||
| 46151286 | Major Shareholding Notification 2026 | 2026-04-30 | English | ||
| 46151283 | Major Shareholding Notification 2026 | 2026-04-28 | English | ||
| 38002356 | 8-K - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-04-28 | English | ||
| 33065533 | 144 - GILEAD SCIENCES, INC. (0000882095) (Subject) | 2026-03-27 | English | ||
| 33053040 | SCHEDULE 13G/A - GILEAD SCIENCES, INC. (0000882095) (Subject) | 2026-03-26 | English | ||
| 33001942 | ARS - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-03-20 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
HARROW, INC.
An eyecare pharmaceutical company that develops and commerc…
|
HROW | US | Manufacturing |
|
HAVN Life Sciences Inc.
Standardized extraction and formulation of psychoactive com…
|
HAVN | CA | Manufacturing |
|
HBM Holdings Limited
Biopharmaceutical company developing novel antibody therape…
|
2142 | KY | Manufacturing |
|
HCW Biologics Inc.
Develops immunotherapies for diseases linked to aging and c…
|
HCWB | US | Manufacturing |
|
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Specializes in the production of heparin-based APIs and ant…
|
300255 | CN | Manufacturing |
|
Hefei Lifeon Pharmaceutical Co., Ltd.
Develops and manufactures cardiovascular, anti-infective, a…
|
003020 | CN | Manufacturing |
|
Heidelberg Pharma AG
Clinical-stage biopharma developing Amanitin-based ADCs for…
|
HPHA | DE | Manufacturing |
|
Heilongjiang ZBD Pharmaceutical Co.,Ltd.
Develops TCM, chemical and biological drugs for cardiovascu…
|
603567 | CN | Manufacturing |
|
Helix BioPharma Corp.
Clinical-stage immune-oncology firm developing bio-conjugat…
|
HBP | CA | Manufacturing |
|
Helixmith Co., Ltd
A biotechnology company specializing in the research and de…
|
084990 | KR | Manufacturing |
GILEAD SCIENCES, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29828/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29828 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29828 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29828 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29828}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GILEAD SCIENCES, INC. (id: 29828)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.